1. Stocks
  2. Regulus Therapeutics Inc
  3. Swot
swot-logo

Regulus Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Regulus Therapeutics Inc has 15 Strengths, 6 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Strength Index (RSI) Bullish

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over Half Year (6 Months)

Relative Outperformance versus Industry over the Quarter (3 Months)

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Near 52 Week High

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Stock gained more than 20% in one month

Increasing profits every quarter for the past 2 quarters

Stocks near 52 Week High with Significant Volumes

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Institutions increasing their shareholding

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Promoters increasing shareholding QoQ